OPFOLDA 65 mg/1
miglustat · CAPSULE · AMICUS THERAPEUTICS US, LLC
Miglustat is an oral medication used to treat certain rare inherited metabolic disorders, such as Gaucher disease and Niemann-Pick disease type C, by slowing the buildup of harmful substances in the body. It works by inhibiting an enzyme involved in the production of these damaging compounds.
Key Facts
- Brand Name
- OPFOLDA
- Generic Name
- miglustat
- NDC Code (Product)
71904-300- Manufacturer
- AMICUS THERAPEUTICS US, LLC
- Strength
- 65 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA215211
- Drug Class
- Glucosylceramide Synthase Inhibitor [EPC]; Enzyme Stabilizer [EPC]
- Marketing Start
- 10/11/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is OPFOLDA used for?
Miglustat is an oral medication used to treat certain rare inherited metabolic disorders, such as Gaucher disease and Niemann-Pick disease type C, by slowing the buildup of harmful substances in the body. It works by inhibiting an enzyme involved in the production of these damaging compounds.
Is OPFOLDA a controlled substance?
OPFOLDA is not classified as a controlled substance by the DEA.
What is the generic name for OPFOLDA?
The generic name for OPFOLDA is miglustat. There are 6 other brand versions of miglustat.
What is the NDC code for OPFOLDA 65 mg/1?
The NDC (National Drug Code) for OPFOLDA 65 mg/1 is 71904-300, listed by AMICUS THERAPEUTICS US, LLC.